Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- IMV.TO
- Price
- -
- Stock movement up
- +- (%)
- Company name
- IMV Inc.
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 13.12M
- Ent value
- 29.84M
- Price/Sales
- 39.75
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 71.56%
- 1 year return
- -90.00%
- 3 year return
- -70.08%
- 5 year return
- -57.50%
- 10 year return
- -19.60%
Last updated: 2024-12-17
DIVIDENDS
IMV.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 39.75 |
| Price to Book | - |
| EV to Sales | 90.44 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 11.71M |
| EPS (TTM) | -0.04 |
| FCF per share (TTM) | -0.04 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 330.00K |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -38.47M |
| Net income (TTM) | -36.73M |
| EPS (TTM) | -0.04 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | -11656.97% |
| Profit margin (TTM) | -11131.21% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 21.22M |
| Net receivables | 1.93M |
| Total current assets | 27.59M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 31.35M |
| Accounts payable | 3.19M |
| Short/Current long term debt | 28.90M |
| Total current liabilities | 9.42M |
| Total liabilities | 37.95M |
| Shareholder's equity | -6.60M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -33.40M |
| Capital expenditures (TTM) | 1.07M |
| Free cash flow (TTM) | -34.47M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -117.18% |
| Return on Invested Capital | -173.47% |
| Cash Return on Invested Capital | -162.78% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| IMV.TO | S&P500 | |
| Current price drop from All-time high | -99.30% | -10.17% |
| Highest price drop | -99.58% | -56.47% |
| Date of highest drop | 27 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -80.95% | -11.07% |
| Avg time to new high | 838 days | 12 days |
| Max time to new high | 3350 days | 1805 days |
COMPANY DETAILS
Marketcap
13.12M
Marketcap category
Small-cap
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Employees
63
Website
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found